author_facet Boulet, Gaëlle A.V.
Benoy, Ina H.
Depuydt, Christophe E.
Horvath, Caroline A.J.
Aerts, Marc
Hens, Niel
Vereecken, Annie J.
Bogers, Johannes J.
Boulet, Gaëlle A.V.
Benoy, Ina H.
Depuydt, Christophe E.
Horvath, Caroline A.J.
Aerts, Marc
Hens, Niel
Vereecken, Annie J.
Bogers, Johannes J.
author Boulet, Gaëlle A.V.
Benoy, Ina H.
Depuydt, Christophe E.
Horvath, Caroline A.J.
Aerts, Marc
Hens, Niel
Vereecken, Annie J.
Bogers, Johannes J.
spellingShingle Boulet, Gaëlle A.V.
Benoy, Ina H.
Depuydt, Christophe E.
Horvath, Caroline A.J.
Aerts, Marc
Hens, Niel
Vereecken, Annie J.
Bogers, Johannes J.
Cancer Epidemiology, Biomarkers & Prevention
Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
Oncology
Epidemiology
author_sort boulet, gaëlle a.v.
spelling Boulet, Gaëlle A.V. Benoy, Ina H. Depuydt, Christophe E. Horvath, Caroline A.J. Aerts, Marc Hens, Niel Vereecken, Annie J. Bogers, Johannes J. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-09-0025 <jats:title>Abstract</jats:title> <jats:p>This retrospective case-control study assessed human papillomavirus 16 (HPV16) viral load and E2/E6 ratio as risk markers for cervical intraepithelial neoplasia (CIN) ≥2 lesions in HPV16-positive women in a routine liquid-based cytology setting. Triplex quantitative PCR for HPV16 E6, E2, and β-globin was done to determine the HPV16 load and the E2/E6 ratio, as a surrogate marker for integration, for women with a negative histologic endpoint (200 controls: 83 normal histology and 117 CIN1) and women with a ≥CIN2 endpoint (180 cases: 41 CIN2, 122 CIN3, and 17 invasive carcinoma). Our analysis showed a significantly higher HPV16 load in the case group, which was completely attributable to the high viral load of samples with invasive carcinoma as histologic endpoint. There was no significant difference in viral load between the other histologic groups. The E2/E6 ratio proved to be lower for the cases. However, the E2/E6 ratio indicated the presence of HPV integration in a considerable amount of control samples (44.3%), which suggests that HPV integration occurs early in the development of cancer and undermines the clinical value of viral integration. Overall, the intrinsic heterogeneous nature of the cervical cytology samples caused a substantial overlap of the HPV16 load and the E2/E6 ratio between controls and cases, which precludes the determination of cutoff values for risk prediction and hampers the clinical applicability in a cervical screening setting. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2992–9)</jats:p> Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting? Cancer Epidemiology, Biomarkers & Prevention
doi_str_mv 10.1158/1055-9965.epi-09-0025
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA5LTAwMjU
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA5LTAwMjU
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint American Association for Cancer Research (AACR), 2009
imprint_str_mv American Association for Cancer Research (AACR), 2009
issn 1055-9965
1538-7755
issn_str_mv 1055-9965
1538-7755
language English
mega_collection American Association for Cancer Research (AACR) (CrossRef)
match_str boulet2009humanpapillomavirus16loadande2e6ratioinhpv16positivewomenbiomarkersforcervicalintraepithelialneoplasia2inaliquidbasedcytologysetting
publishDateSort 2009
publisher American Association for Cancer Research (AACR)
recordtype ai
record_format ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
title Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_unstemmed Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_full Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_fullStr Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_full_unstemmed Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_short Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_sort human papillomavirus 16 load and e2/e6 ratio in hpv16-positive women: biomarkers for cervical intraepithelial neoplasia ≥2 in a liquid-based cytology setting?
topic Oncology
Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-09-0025
publishDate 2009
physical 2992-2999
description <jats:title>Abstract</jats:title> <jats:p>This retrospective case-control study assessed human papillomavirus 16 (HPV16) viral load and E2/E6 ratio as risk markers for cervical intraepithelial neoplasia (CIN) ≥2 lesions in HPV16-positive women in a routine liquid-based cytology setting. Triplex quantitative PCR for HPV16 E6, E2, and β-globin was done to determine the HPV16 load and the E2/E6 ratio, as a surrogate marker for integration, for women with a negative histologic endpoint (200 controls: 83 normal histology and 117 CIN1) and women with a ≥CIN2 endpoint (180 cases: 41 CIN2, 122 CIN3, and 17 invasive carcinoma). Our analysis showed a significantly higher HPV16 load in the case group, which was completely attributable to the high viral load of samples with invasive carcinoma as histologic endpoint. There was no significant difference in viral load between the other histologic groups. The E2/E6 ratio proved to be lower for the cases. However, the E2/E6 ratio indicated the presence of HPV integration in a considerable amount of control samples (44.3%), which suggests that HPV integration occurs early in the development of cancer and undermines the clinical value of viral integration. Overall, the intrinsic heterogeneous nature of the cervical cytology samples caused a substantial overlap of the HPV16 load and the E2/E6 ratio between controls and cases, which precludes the determination of cutoff values for risk prediction and hampers the clinical applicability in a cervical screening setting. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2992–9)</jats:p>
container_issue 11
container_start_page 2992
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 18
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792348755882672130
geogr_code not assigned
last_indexed 2024-03-01T18:15:53.832Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Human+Papillomavirus+16+Load+and+E2%2FE6+Ratio+in+HPV16-Positive+Women%3A+Biomarkers+for+Cervical+Intraepithelial+Neoplasia+%E2%89%A52+in+a+Liquid-Based+Cytology+Setting%3F&rft.date=2009-11-01&genre=article&issn=1538-7755&volume=18&issue=11&spage=2992&epage=2999&pages=2992-2999&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Human+Papillomavirus+16+Load+and+E2%2FE6+Ratio+in+HPV16-Positive+Women%3A+Biomarkers+for+Cervical+Intraepithelial+Neoplasia+%E2%89%A52+in+a+Liquid-Based+Cytology+Setting%3F&aulast=Bogers&aufirst=Johannes+J.&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-09-0025&rft.language%5B0%5D=eng
SOLR
_version_ 1792348755882672130
author Boulet, Gaëlle A.V., Benoy, Ina H., Depuydt, Christophe E., Horvath, Caroline A.J., Aerts, Marc, Hens, Niel, Vereecken, Annie J., Bogers, Johannes J.
author_facet Boulet, Gaëlle A.V., Benoy, Ina H., Depuydt, Christophe E., Horvath, Caroline A.J., Aerts, Marc, Hens, Niel, Vereecken, Annie J., Bogers, Johannes J., Boulet, Gaëlle A.V., Benoy, Ina H., Depuydt, Christophe E., Horvath, Caroline A.J., Aerts, Marc, Hens, Niel, Vereecken, Annie J., Bogers, Johannes J.
author_sort boulet, gaëlle a.v.
container_issue 11
container_start_page 2992
container_title Cancer Epidemiology, Biomarkers & Prevention
container_volume 18
description <jats:title>Abstract</jats:title> <jats:p>This retrospective case-control study assessed human papillomavirus 16 (HPV16) viral load and E2/E6 ratio as risk markers for cervical intraepithelial neoplasia (CIN) ≥2 lesions in HPV16-positive women in a routine liquid-based cytology setting. Triplex quantitative PCR for HPV16 E6, E2, and β-globin was done to determine the HPV16 load and the E2/E6 ratio, as a surrogate marker for integration, for women with a negative histologic endpoint (200 controls: 83 normal histology and 117 CIN1) and women with a ≥CIN2 endpoint (180 cases: 41 CIN2, 122 CIN3, and 17 invasive carcinoma). Our analysis showed a significantly higher HPV16 load in the case group, which was completely attributable to the high viral load of samples with invasive carcinoma as histologic endpoint. There was no significant difference in viral load between the other histologic groups. The E2/E6 ratio proved to be lower for the cases. However, the E2/E6 ratio indicated the presence of HPV integration in a considerable amount of control samples (44.3%), which suggests that HPV integration occurs early in the development of cancer and undermines the clinical value of viral integration. Overall, the intrinsic heterogeneous nature of the cervical cytology samples caused a substantial overlap of the HPV16 load and the E2/E6 ratio between controls and cases, which precludes the determination of cutoff values for risk prediction and hampers the clinical applicability in a cervical screening setting. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2992–9)</jats:p>
doi_str_mv 10.1158/1055-9965.epi-09-0025
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA5LTAwMjU
imprint American Association for Cancer Research (AACR), 2009
imprint_str_mv American Association for Cancer Research (AACR), 2009
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 1055-9965, 1538-7755
issn_str_mv 1055-9965, 1538-7755
language English
last_indexed 2024-03-01T18:15:53.832Z
match_str boulet2009humanpapillomavirus16loadande2e6ratioinhpv16positivewomenbiomarkersforcervicalintraepithelialneoplasia2inaliquidbasedcytologysetting
mega_collection American Association for Cancer Research (AACR) (CrossRef)
physical 2992-2999
publishDate 2009
publishDateSort 2009
publisher American Association for Cancer Research (AACR)
record_format ai
recordtype ai
series Cancer Epidemiology, Biomarkers & Prevention
source_id 49
spelling Boulet, Gaëlle A.V. Benoy, Ina H. Depuydt, Christophe E. Horvath, Caroline A.J. Aerts, Marc Hens, Niel Vereecken, Annie J. Bogers, Johannes J. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-09-0025 <jats:title>Abstract</jats:title> <jats:p>This retrospective case-control study assessed human papillomavirus 16 (HPV16) viral load and E2/E6 ratio as risk markers for cervical intraepithelial neoplasia (CIN) ≥2 lesions in HPV16-positive women in a routine liquid-based cytology setting. Triplex quantitative PCR for HPV16 E6, E2, and β-globin was done to determine the HPV16 load and the E2/E6 ratio, as a surrogate marker for integration, for women with a negative histologic endpoint (200 controls: 83 normal histology and 117 CIN1) and women with a ≥CIN2 endpoint (180 cases: 41 CIN2, 122 CIN3, and 17 invasive carcinoma). Our analysis showed a significantly higher HPV16 load in the case group, which was completely attributable to the high viral load of samples with invasive carcinoma as histologic endpoint. There was no significant difference in viral load between the other histologic groups. The E2/E6 ratio proved to be lower for the cases. However, the E2/E6 ratio indicated the presence of HPV integration in a considerable amount of control samples (44.3%), which suggests that HPV integration occurs early in the development of cancer and undermines the clinical value of viral integration. Overall, the intrinsic heterogeneous nature of the cervical cytology samples caused a substantial overlap of the HPV16 load and the E2/E6 ratio between controls and cases, which precludes the determination of cutoff values for risk prediction and hampers the clinical applicability in a cervical screening setting. (Cancer Epidemiol Biomarkers Prev 2009;18(11):2992–9)</jats:p> Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting? Cancer Epidemiology, Biomarkers & Prevention
spellingShingle Boulet, Gaëlle A.V., Benoy, Ina H., Depuydt, Christophe E., Horvath, Caroline A.J., Aerts, Marc, Hens, Niel, Vereecken, Annie J., Bogers, Johannes J., Cancer Epidemiology, Biomarkers & Prevention, Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?, Oncology, Epidemiology
title Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_full Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_fullStr Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_full_unstemmed Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_short Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
title_sort human papillomavirus 16 load and e2/e6 ratio in hpv16-positive women: biomarkers for cervical intraepithelial neoplasia ≥2 in a liquid-based cytology setting?
title_unstemmed Human Papillomavirus 16 Load and E2/E6 Ratio in HPV16-Positive Women: Biomarkers for Cervical Intraepithelial Neoplasia ≥2 in a Liquid-Based Cytology Setting?
topic Oncology, Epidemiology
url http://dx.doi.org/10.1158/1055-9965.epi-09-0025